SCHEMBL9534968

SCHEMBL9534968

CCCCCc1cn(C2CCCCC2)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 8/20 0.48
AGTR2 P50052 7/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9532949 0.99 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9035831 0.97 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL9036983 0.97 AGTR1 (0.51) AGTR1AGTR2
SCHEMBL9034820 0.95 AGTR1 (0.46) AGTR1AGTR2
SCHEMBL9036604 0.93 AGTR1 (0.53) AGTR1AGTR2
SCHEMBL9532240 0.91 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL7678987 0.90 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL7682683 0.90 AGTR1 (0.41) AGTR1AGTR2
SCHEMBL7679906 0.90 AGTR1 (0.43) AGTR1AGTR2
SCHEMBL7676750 0.90 AGTR1 (0.43) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed